Corcept Therapeutics Incorporated - Rasio total nilai perusahaan marang pendapatan CORT

Logo perusahaan publik Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics (CORT) is scaling its portfolio of cortisol modulators to combat oncology and metabolic disorders. The firm's EV/Sales multiple valuation demonstrates this growth, while the 7004.52 metric indicates the status of its current value. Success is based on its monopoly in Cushing's syndrome therapy and Korlym, as well as scientific partnerships with leading endocrinology centers to develop complex treatment methods.

CORT Corcept Therapeutics: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

CORT (corcept.com): rincian analitis lan laporan miturut indikator

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:Corcept Therapeutics CORT
Produk asil prodhuksi Corcept Therapeutics

This indicator determines the enterprise value of Corcept Therapeutics (CORT) by accounting for net debt and comparing it to sales volume to eliminate the impact of financial leverage. By analyzing the EV/Revenue ratio on the GURU.Markets platform, an investor assesses the monetization efficiency of drugs for the therapy of Cushing's syndrome, where a high valuation is justified by patent exclusivity and the growth potential of the metabolic correction market.

Analisis pesaing Corcept Therapeutics

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|RYTM - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Akero Corp|Metsera Therapeutics (MTSR) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan moonlaketx.com (MLTX)|Nilai perusahaan marang pendapatan Crinetics Pharmaceuticals CRNX|Rasio nilai perusahaan marang pendapatan NewAmsterdam Pharma N.V. NAMS|Rasio total nilai perusahaan marang pendapatan Soleno Therapeutics Inc (SLNO)|FOLD - Rasio nilai perusahaan marang pendapatan|ETNB: Rasio nilai perusahaan marang pendapatan|AGIO: Multiplikator EV/Sales|Structure Therapeutics Inc. - Nilai bisnis marang pendapatan|MDXG (MiMedx Corp) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Rezolute Inc RZLT|Multiplikator EV/Sales LXRX|Rasio total nilai perusahaan marang pendapatan MBX Corp|Altimmune Pharma - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales aardvarktherapeutics.com AARD|SGMT: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BIOA (BioAge Labs)|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)